Chikungunyavirus-sykdom: Prognose
Gjennomgått infeksjon med Chikungunyavirus gir for de aller fleste livslang immunitet mot ny infeksjon.
Prognosen er god for ellers friske personer. Men alvorlig sykdom med lunge- og hjertesvikt og infeksjon i sentralnervesystemet kan forekomme hos personer med svekket immunsystem.
Annonse
Vil du vite mer
Dette dokumentet er basert på det profesjonelle dokumentet Chikungunyavirus-sykdom . Referanselisten for dette dokumentet vises nedenfor
Referanser
- Vu DM, Jungkind D, Angelle Desiree LaBeaud. Chikungunya Virus. Clin Lab Med. 2017;37(2):371-382. PubMed
- Smittevernhåndboka. Chikungunyavirus-sykdom - håndbok for helsepersonell. Folkehelseinstituttet, sist endret 04.03.2025. www.fhi.no
- Zumla A, Ntoumi F, Ippolito G; PANDORA-ID-NET Consortium. Chikungunya virus disease returns to Europe: a turning point for the global arboviral landscape. Lancet. 2025 Jul 23:S0140-6736(25)01458-8. PMID: 40713986. PubMed
- Parola P, de Lamballerie X, Jourdan J, et al. Novel Chikungunya virus variant in travelers returning from Indian Ocean islands. Emerg Infect Dis 2006; 12: 1493-9. PubMed
- Vouga M, Chiu YC, Pomar L, et al. Dengue, Zika and chikungunya during pregnancy: pre- and post-travel advice and clinical management. J Travel Med. 2019 Dec 23;26(8):taz077. PMID: 31616923. PubMed
- Centers for Disease Control and Prevention. Chikungunya Virus. Symptoms, Diagnosis and Treatment. 2022. www.cdc.gov
- Charrel RN, de Lamballerie X,Raoult D. Chikungunya outbreaks - the globalization of vectorborne diseases. N Engl J Med 2007; 356: 769-71. PubMed
- Simon F, Savini H, Parola P. Chikungunya: a paradigm of emergence and globalization of vector-borne diseases. Med Clin North Am 2008; 92:1323. PubMed
- Richardson JS, Anderson DM, Mendy J,et al. Chikungunya virus virus-like particle vaccine safety and immunogenicity in adolescents and adults in the USA: a phase 3, randomised, double-blind, placebo-controlled trial. Lancet. 2025 Apr 19;405(10487):1343-1352. Epub 2025 Mar 27. PMID: 40158526. PubMed
- The European Medicines Agency (EMA): New Chikungunya vaccine for adolescents from 12 and adults. 31 January 2025. Nettside besøkt 22.04.25. www.ema.europa.eu
- Vaksinasjonshåndboka. Chikungunyavirusvaksine. Folkehelseinstituttet, publisert 04.03.2025. Nettsiden besøkt 22.04.25 www.fhi.no
- Gerardin P, Couderc T, Bintner M, et al. Chikungunya virus - associated encephalitis. Neurology 2015. doi:10.1212/WNL.0000000000002234
- de Souza WM, Fumagalli MJ, de Lima STS, et al. Pathophysiology of chikungunya virus infection associated with fatal outcomes. Cell Host Microbe 2024; 32: 606-622. pmid:38479396 PubMed